{"id":"NCT00561821","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)","officialTitle":"A Double-Blind, Randomized, Parallel Group, Placebo- Controlled Sleep Laboratory Efficacy and Safety Study With Org 50081 in Elderly Subjects With Chronic Primary Insomnia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11-20","primaryCompletion":"2009-12-21","completion":"2009-12-21","firstPosted":"2007-11-21","resultsPosted":"2014-08-05","lastUpdate":"2018-10-03"},"enrollment":538,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Insomnia","Sleep Initiation and Maintenance Disorders","Mental Disorders","Dyssomnias","Sleep Disorders"],"interventions":[{"type":"DRUG","name":"Esmirtazapine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Esmirtazapine 0.5 mg","type":"EXPERIMENTAL"},{"label":"Esmirtazapine 1.5 mg","type":"EXPERIMENTAL"},{"label":"Esmirtazapine 3.0 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study was conducted to investigate the efficacy of treatment with Org 50081 (Esmirtazapine)\n\ncompared to placebo in elderly participants with chronic primary\n\ninsomnia. Primary efficacy variable is Wake time After Sleep\n\nOnset (WASO), averaged over all in-treatment time points\n\nand measured by polysomnography (PSG).","primaryOutcome":{"measure":"Average Wake Time After Sleep Onset Measured by Polysomnography","timeFrame":"Up to Day 16","effectByArm":[{"arm":"Esmirtazapine 0.5 mg","deltaMin":80.3,"sd":36.5},{"arm":"Esmirtazapine 1.5 mg","deltaMin":79.6,"sd":30.7},{"arm":"Esmirtazapine 3.0 mg","deltaMin":74.8,"sd":28},{"arm":"Placebo","deltaMin":109.8,"sd":42.1}],"pValues":[{"comp":"OG000 vs OG003","p":"<0.0001"},{"comp":"OG001 vs OG003","p":"<0.0001"},{"comp":"OG002 vs OG003","p":"<0.0001"}]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":20},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":132},"commonTop":["Somnolence","Fatigue","Dizziness"]}}